Filing Details
- Accession Number:
- 0001870913-23-000018
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-20 21:05:59
- Reporting Period:
- 2023-11-17
- Accepted Time:
- 2023-11-20 21:05:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1023024 | Ani Pharmaceuticals Inc | ANIP | Pharmaceutical Preparations (2834) | 582301143 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1870913 | Muthusamy Shanmugam | C/O Ani Pharmaceuticals, Inc. 210 Main Street West Baudette MN 56623 | Head Of R&D, Coo-Novitium Ops | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-11-17 | 13,000 | $51.00 | 982,620 | No | 4 | S | Indirect | Held by Esjay LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | Held by Esjay LLC |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 47,407 | Direct | |
| Common Stock | 5,000 | Indirect | Held by SS Pharma LLC |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $50.70 to $51.43, inclusive.
- The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
- The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC.
Billionaire Hedge Funds
